ESR1 and breast carcinoma: In this context, tamoxifen (TAM), an estrogen receptor modulator clinically used in the treatment of breast cancer, has been demonstrated to also be effective in treating abnormal healing disorders, such as retroperitoneal fibrosis, sclerosing encapsulated peritonitis, fibrosing mediastinitis, among other fibroproliferative conditions15–18.